- Low
- 65,731
- Average
- 65,731
- Median
- 65,731
- High
- 65,731
Neuralstem Salary
36
54
75
Neuralstem average salary is $65,731, median salary is $65,731 with a salary range from $65,731 to $65,731.
Neuralstem salaries are collected from government agencies and companies. Each salary is associated with a real job position. Neuralstem salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
Neuralstem salaries are collected from government agencies and companies. Each salary is associated with a real job position. Neuralstem salary statistics is not exclusive and is for reference only. They are presented "as is" and updated regularly.
| Job Title | Salaries | City | Year | More info |
| Applications Programmer | 65,731-65,731 | Redlands, CA, 92373 | 2012 | Neuralstem Applications Programmer Salaries (1) Neuralstem Redlands, CA Salaries |
Related Neuralstem Salary
Calculate how much you could earn
It's FREE. Based on your input and our analysis. How we do it?
All fields are required for calculation accuracy.
- We will send you an email to access your personalized report.
- We won’t share your email address
Neuralstem salary is full-time annual starting salary. Intern, contractor and hourly pay scale vary from regular exempt employee. Compensation depends on work experience, job location, bonus, benefits and other factors.
Real Jobs Salary - Salary List- 8.5 million company & government reported salaries with date & location
- Salary calculator rank & calculate your salary
- 151 million W-2s pay scale statistics in U.S.
- Salary Map helps you navigate location based salary information
- State & City Salary provides wage data by metropolitan areas
- Company Salaries has salaries data from over 200,000 companies
Neuralstem Jobs
| See more Neuralstem Jobs» | |
| Search All Jobs | |
Neuralstem... Information
- Neuralstem, Inc
- Industry: Biotech/Healthcare
- City: Rockville, MD
- Neuralstem's patent-protected technology enables, for the first time, the ability to produce neural stem cells of the human brain and spinal cord in commercial quantities, and the ability to control the differentiation of these cells into mature, physiologically relevant human neurons and glia. The Company expects that its first Investigational New Drug (IND) application will be for the treatment of Ischemic Spastic Paraplegia, a form of paraplegia that sometimes results from the surgery to repair aortic aneurysms and for which there is no effective treatment. The Company hopes to submit its initial IND application to the FDA and begin its
